-
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
Rodriguez-Mogeda, C., van Lierop, Z. Y. G. J., van der Pol, S. M. A., Coenen, L., Hogenboom, L., Kamermans, A., Rodriguez, E., van Horssen, J., van Kempen, Z. L. E., Uitdehaag, B. M. J., Teunissen, C. E., Witte, M. E., Killestein, J. & de Vries, H. E., Dec 2023, In: Journal of neuroinflammation. 20, 1, p. 215 215.Research output: Contribution to journal › Article › Academic › peer-review
-
Correction: Nectins and Nectin-like molecules drive vascular development and barrier function (Angiogenesis, (2023), 26, 3, (349-362), 10.1007/s10456-023-09871-y)
Hermans, D., Rodriguez-Mogeda, C., Kemps, H., Bronckaers, A., de Vries, H. E. & Broux, B., Aug 2023, In: Angiogenesis. 26, 3, p. 363 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Nectins and Nectin-like molecules drive vascular development and barrier function
Hermans, D., Rodriguez-Mogeda, C., Kemps, H., Bronckaers, A., de Vries Helga, E. & Broux, B., Aug 2023, In: Angiogenesis. 26, 3, p. 349-362 14 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications